STOCKS SURGE AS RATE-HIKE FEARS FADE, WITH APPLE ON DECK

Paramount shares jump on Sony, Apollo US$26 billion buyout offer: Report

AlzeCure Pharma AB (publ) (AC6.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

0.1205

-0.0150

(-11.07%)

At close: 10:18AM CEST

Loading interactive chart...

ACCESSWIRE
AlzeCure Publishes its Interim Report for January - March 2024
STOCKHOLM, SWEDEN / ACCESSWIRE / April 25, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - March 2024 is now available on the company's website: ...
ACCESSWIRE
Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board
STOCKHOLM, SWEDEN / ACCESSWIRE / April 10, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB ("AlzeCure" or "the Company"), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and ...
ACCESSWIRE
AlzeCure Pharma Publishes its Annual Report for 2023
STOCKHOLM, SE / ACCESSWIRE / April 4, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central ...